Functional and association analysis of an Amerindian-derived population-specific p.(Thr280Met) variant in RBPJL , a component of the PTF1 complex

Anup K. Nair,Jeff R. Sutherland,Michael Traurig,Paolo Piaggi,Peng Chen,Sayuko Kobes,Robert L. Hanson,Clifton Bogardus,Leslie J. Baier
DOI: https://doi.org/10.1038/s41431-017-0062-6
2018-01-01
European Journal of Human Genetics
Abstract:PTF1 complex is critical for pancreatic development and maintenance of adult exocrine pancreas. As a part of our ongoing studies to identify genetic variation that contributes to type 2 diabetes (T2D) in American Indians, we analyzed variation in genes that form this complex, namely PTF1A , RBPJ , and its paralogue RBPJL . A c.839C>T (p.(Thr280Met)) variant (rs200998587:C>T, risk allele frequency = 0.03) in RBPJL , identified only in Amerindian-derived populations, associated with T2D (OR = 1.60[1.21–2.13] per Met allele, P = 0.001) and age of diabetes onset (HR = 1.40[1.14–1.72], P = 0.001). Knockdown of Rbpjl in mouse pancreatic acinar cells resulted in a significant decrease in the mRNA expression of genes encoding exocrine enzymes including Ctrb . CTRB1/2 is an established T2D locus where the protective allele associates with increased GLP-1-stimulated insulin secretion and higher expression of CTRB1 / 2 . In vitro studies show that cells expressing the Met280 allele had lower RBPJL protein levels than cells expressing the Thr280 allele, despite having comparable levels of RNA, suggesting that the Met280 RBPJL is less stable. Additionally, luciferase assays in HEK293 cells which examined two different RBPJL responsive promoters, including the promoter for CTRB1 , also identified reduced transactivation by the Met280 RBPJL. Similarly, overexpression of both Met280 and Thr280 RBPJL in mouse pancreatic acinar cells identified a significant impairment in the expression of Cel when transactivated by the Met280 RBPJL. In summary, we identified a functional, Amerindian-derived population-specific c.839C>T (p.(Thr280Met)) variant in the pancreas specific RBPJL that may modify T2D risk by regulating exocrine enzyme expression.
What problem does this paper attempt to address?